Catalog No. 

CS565166

Species reactivity 

SARS-CoV-2(2019-nCoV)

Applications 

Research Grade Biosimilar

Host species

Chimeric

Isotype 

[VH-h-CH2-CH3]-dimer

Expression system 

Mammalian Cells

Clonality 

Monoclonal

Target

Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2, Receptor-Binding Domain, RBD

Concentration 

1mg/ml

Endotoxin level 

Please contact the lab for this information.

Purity 

>95% purity as determined by SDS-PAGE.

Purification 

Protein A/G, purified from cell culture supernatant.

Accession 

P0DTC2-2

Form 

Liquid

Storage buffer 

0.01M PBS,pH7.4.

Stability and Storage 

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -777°C.

Alternate Names 

VHH-72-Fc,XVR011CAS:2540797-21-3

Background 

Rimteravimab (XVR011) is a bivalent VHH-Fc antibody with potent neutralizing activity with high stability, broad coverage and silenced Fc effector functions against the disease caused by SARS-CoV-2.

Note

For research use only. Not for use in clinical or therapeutic applications.